509 related articles for article (PubMed ID: 8800113)
21. Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
Giamouzis G; Butler J; Starling RC; Karayannis G; Nastas J; Parisis C; Rovithis D; Economou D; Savvatis K; Kirlidis T; Tsaknakis T; Skoularigis J; Westermann D; Tschöpe C; Triposkiadis F
J Card Fail; 2010 Dec; 16(12):922-30. PubMed ID: 21111980
[TBL] [Abstract][Full Text] [Related]
22. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
[TBL] [Abstract][Full Text] [Related]
23. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Ng KT; Yap JLL
Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
[TBL] [Abstract][Full Text] [Related]
24. Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure.
Allen LA; Turer AT; Dewald T; Stough WG; Cotter G; O'Connor CM
Am J Cardiol; 2010 Jun; 105(12):1794-7. PubMed ID: 20538132
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the Dopamine in Acute Decompensated Heart Failure II (DAD-HF II) trial.
Triposkiadis FK; Butler J; Karayannis G; Starling RC; Filippatos G; Wolski K; Parissis J; Parisis C; Rovithis D; Koutrakis K; Skoularigis J; Antoniou CK; Chrysohoou C; Pitsavos C; Stefanadis C; Nastas J; Tsaknakis T; Mantziari L; Giannakoulas G; Karvounis H; Kalogeropoulos AP; Giamouzis G
Int J Cardiol; 2014 Mar; 172(1):115-21. PubMed ID: 24485633
[TBL] [Abstract][Full Text] [Related]
26. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
27. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
[TBL] [Abstract][Full Text] [Related]
28. Variable furosemide absorption and poor predictability of response in elderly patients.
Murray MD; Haag KM; Black PK; Hall SD; Brater DC
Pharmacotherapy; 1997; 17(1):98-106. PubMed ID: 9017769
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
Sjöström P
Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
[TBL] [Abstract][Full Text] [Related]
30. Comparison of 6-hour infusion versus bolus furosemide in premature infants.
Reiter PD; Makhlouf R; Stiles AD
Pharmacotherapy; 1998; 18(1):63-8. PubMed ID: 9469683
[TBL] [Abstract][Full Text] [Related]
31. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
[TBL] [Abstract][Full Text] [Related]
32. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.
van Meyel JJ; Smits P; Dormans T; Gerlag PG; Russel FG; Gribnau FW
J Intern Med; 1994 Apr; 235(4):329-34. PubMed ID: 8151264
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of a furosemide continuous infusion following cardiac surgery.
Gulbis BE; Spencer AP
Ann Pharmacother; 2006 Oct; 40(10):1797-803. PubMed ID: 16954328
[TBL] [Abstract][Full Text] [Related]
34. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs.
Adin DB; Taylor AW; Hill RC; Scott KC; Martin FG
J Vet Intern Med; 2003; 17(5):632-6. PubMed ID: 14529128
[TBL] [Abstract][Full Text] [Related]
35. [Continuous infusion versus bolus injection of loop diuretics in acute heart failure: a literature review].
Leto L; Aspromonte N; Feola M
G Ital Cardiol (Rome); 2012 Apr; 13(4):263-72. PubMed ID: 22495643
[TBL] [Abstract][Full Text] [Related]
36. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
[TBL] [Abstract][Full Text] [Related]
37. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
[TBL] [Abstract][Full Text] [Related]
38. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
Verma AK; da Silva JH; Kuhl DR
Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
Baruch L; Patacsil P; Hameed A; Pina I; Loh E
Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
[TBL] [Abstract][Full Text] [Related]
40. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F
Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
